The cluster of director and CLO sales at $43.60-$45.50 with no insider purchases suggests a lack of conviction at current levels. Monitor for upcoming clinical data readouts or financing events that may have prompted the selling. The OrbiMed director sale of $5.27M is the largest and most notable, OrbiMed is a significant healthcare investor, and a director-level sale of this size may signal a view on near-term valuation ceiling.
SION drugs
SION drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 10 $45.29entry
- T+1 · 4mo ago −2.96%α −2.19% · $43.95
- T+5 · 4mo ago 0.00%α +0.56% · $45.29
- T+20 · 3mo ago +12.70%α +10.27% · $51.04
- T+60 · 6w ago −89.29%α −91.92% · $4.85
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Sionna insiders sold a combined $9.57M in open-market sales over a 7-day window, including a director ($5.27M) and the Chief Legal Officer ($447K). The total sales represent ~0.48% of the $2.0B market cap, a modest but notable cluster. No insider purchases occurred, and the selling is concentrated among directors and a C-suite officer, with no 10b5-1 pattern evident. This cluster signals potential insider caution ahead of upcoming catalysts or data readouts.
Key Financial Metrics
Key Facts
- Three insiders sold a total of ~$9.57M in open-market sales over a 7-day window (June 30, July 7, 2026).
- OrbiMed Advisors LLC (Director) sold 115.8K shares at $45.50 for $5.27M on June 30.
- Director Peter A. Thompson sold 85.9K shares at $44.86 for $3.85M on July 7.
- Chief Legal Officer Jennifer Fitzpatrick sold 10.3K shares at $43.60 for $447K on July 6, after exercising options.
- Total open-market sales of ~$9.57M represent ~0.48% of SION's $2.0B market cap, a modest but notable cluster.
- No insider purchases were made during the window.
- The cluster includes two directors and one C-suite officer, with no 10b5-1 pattern evident.
Financial Impact
Total insider sales of ~$9.57M represent ~0.48% of SION's $2.0B market cap, modest but notable for a pre-commercial biotech.
Risk Factors
- Insider selling cluster with no purchases suggests limited confidence at current valuation.
- OrbiMed director sale of $5.27M is the largest single trade and may signal a view on near-term ceiling.
- No 10b5-1 pattern evident, sales appear discretionary.
- Pre-commercial biotech with no approved products, valuation dependent on pipeline milestones.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SION-1783630882064 |
Track record
22 reports on SION
7 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +88.41% at T+60 after the Jul 7, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 10, 20266d ago Press Release Neutral 5/10 Entry $3.70 Now $3.12 −15.68% settles Nov 17
- Nov 9, 20267d ago SC 13G Neutral 3/10 Entry $3.57 to $3.12 Now $3.12 −12.61% ▼ −12.61% −10.91% vs SPY
- Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $3.65 to $3.70 Now $3.12 −14.52% ▲ +1.37% +1.96% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 3/10 Entry $6.02 to $5.15 Now $3.12 −48.17% ▼ −14.45% −13.26% vs SPY
- Sep 21, 20268w ago SC 13D/A Bearish 7/10 Entry $6.02 to $5.15 Now $3.12 +48.17% ▲ +14.45% +13.26% vs SPY
- Sep 17, 20268w ago 144 Bearish 5/10 Entry $5.96 to $5.23 Now $3.12 +47.65% ▲ +12.25% +13.52% vs SPY
- Aug 10, 202614w ago 8-K Bearish 7/10 Entry $4.50 to $5.91 Now $3.12 +30.67% ▼ −31.33% −31.38% vs SPY
- Aug 6, 202614w ago 8-K Neutral 4/10 Entry $49.61 to $6.54 Now $3.12 −93.71% ▼ −86.82% −88.03% vs SPY
- Jul 9, 202618w ago Insider Cluster Neutral 4/10 Entry $45.29 to $45.29 Now $3.12 −93.11% · 0.00% +0.56% vs SPY
- Jul 9, 202618w ago Insider Cluster Bearish 5/10 Viewing Entry $45.29 to $45.29 Now $3.12 +93.11% · 0.00% −0.56% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers